Articles about 'AstraZeneca

The University of Cambridge, AstraZeneca and Beijing municipal parties (the Beijing Science and Technology Commission and the Beijing Economic and Technological Development Area), have signed an agreement that will enhance collaboration between the University, AstraZeneca and Cambridge and Beijing’s life sciences ecosystems.

Highlighting the last 10 years of partnership through scientific collaboration, nurturing talent and strengthening our ecosystem

Together and separately, AstraZeneca and the University are both deeply committed to partnering with the local community.

A joint University and AstraZeneca course is helping to meet the UK’s need for specialist training in clinical pharmacology and pharmaceutical medicine.

A case study of how AstraZeneca is nurturing the talent of the future through its funded PhD programmes.

New Cambridge laboratory supports the UK’s ambition of having the most advanced genomic healthcare system in the world.

Cambridge and AstraZeneca are developing talent and innovation through mentoring programmes, business accelerators and careers support for students.

Making advances in patient care through scientific collaboration and partnering on clinical trials.

Advancing patient care by combining breakthrough science from the University of Cambridge with AstraZeneca’s drug development capabilities.

Together Cambridge and AstraZeneca have a vital role to play in our ecosystem delivering benefits to the economy and society locally and nationally